Cardiovascular Disease (CVD) is the leading cause of death for women in Europe, and the risk of developing this disease increases as women experience menopause and perimenopause.
The CARAMEL (CArdiovascular Risk Assessment in MEnopausaL women) project aims to revolutionise the prevention of cardiovascular disease (CVD) in women aged 40-60 by delivering an innovative, AI-supported model for personalized risk assessment and preventive healthcare.
The project involves 25 global partners across Europe and South America, including Trinity College Dublin.
The research team have already engaged with over 1,200 women in Ireland during the initial stages of the project, to hear about their personal experiences of menopause, perimenopause and heart health, and the healthcare that they received.
Now, they would like to involve clinicians, nurses, midwives, doctors (gynaecologists and cardiovascular physicians) and other specialists in women’s health or cardiovascular care.
Dr Sharon O’Donnell, Associate Professor in Critical Care Nursing, and CARAMEL lead at the School of Nursing and Midwifery said:
“We’ve heard directly from women in Ireland and now we would love input from the clinical staff who are providing care to these women as they experience menopause, perimenopause and cardiovascular health issues.
CARAMEL will bring the voices of these women and the clinical experts together and will engage them in the co-creation of innovative digital solutions, including a new App which will support women with the knowledge, strategies and tools to learn about and strengthen their heart health throughout menopause and perimenopause.
This new approach to personalised cardiovascular disease prevention will be designed for women, by women, in collaboration with healthcare professionals.”
Healthcare professionals interested in contributing to the research can add their details here and the research team will be in touch with more information.
CARAMEL has received funding of almost 12 million euros from the European Union’s Horizon Europe Research and Innovation Programme under Grant Agreement No 101156210.